Soverini, Simona http://orcid.org/0000-0002-4508-0353
Abruzzese, Elisabetta
Bocchia, Monica
Bonifacio, Massimiliano
Galimberti, Sara
Gozzini, Antonella
Iurlo, Alessandra
Luciano, Luigiana
Pregno, Patrizia
Rosti, Gianantonio
Saglio, Giuseppe
Stagno, Fabio
Tiribelli, Mario
Vigneri, Paolo
Barosi, Giovanni
Breccia, Massimo
Article History
Received: 13 August 2019
Accepted: 27 October 2019
First Online: 5 December 2019
Ethics approval and consent to participate
: This is not applicable for this review.
: This is not applicable for this review.
: SS: honoraria from Incyte Biosciences, Novartis, Bristol-Myers Squibb; MB: honoraria from Novartis, Incyte Biosciences, Pfizer, Celgene; SG: speaker fees from Pfizer, Novartis, Incyte Biosciences; AI: honoraria from Novartis, Pfizer and Incyte Biosciences; GR: honoraria from Novartis, Bristol-Myers Squibb, Pfizer, Incyte Biosciences; FS, honoraria from BMS, Incyte Biosciences, Novartis, Pfizer; MT: honoraria from and speakers’ bureau for Novartis, BMS, Pfizer, and Incyte Biosciences; PV: honoraria from Astra Zeneca, Celgene, Incyte Biosciences, Italfarmaco, Novartis, Pfizer, Tesaro, Teva and research funding from Novartis and Pfizer; PP: honoraria from Novartis, Incyte Biosciences, Bristol-Myers Squibb, Pfizer. The remaining authors have no conflicts of interest to disclose.